Hospice = comfort-focused care for patients with prognosis โค 6 months. It's a Medicare benefit, not giving up. Patients and families consistently say they wish hospice was offered earlier. Know the disease-specific criteria.
๐๏ธ Hospice Eligibility
General Criteria (All Diseases)
Prognosis โค 6 months if disease runs its expected course (physician certification)
Patient (or surrogate) elects comfort-focused care -no curative intent treatments
General decline indicators: Karnofsky < 50% or PPS โค 50%, recurrent hospitalizations, progressive weight loss (> 10% in 6 months), declining functional status (increasing dependence in ADLs), albumin < 2.5
"Surprise question": "Would you be surprised if this patient died in the next 6 months?" If no โ hospice referral appropriate. SUPPORT Study, 1995
Disease-Specific Criteria
Disease
Hospice-Eligible When
Heart Failure
NYHA Class IV at rest despite optimal therapy. EF โค 20%. Recurrent hospitalizations (โฅ 3 in 6 months). Refractory to diuretics. Not a candidate for transplant/LVAD. Symptomatic hypotension limiting meds.
COPD / Pulmonary
FEVโ < 30% predicted. Resting dyspnea on max therapy. Oโ-dependent. Cor pulmonale / RHF. Recurrent exacerbations requiring hospitalization. pCOโ > 50 or Oโ sat โค 88% on room air.
Dementia
FAST scale โฅ 7 (unable to ambulate, dress, bathe without assistance; < 6 intelligible words). Plus โฅ 1 complication in past 12 months: aspiration pneumonia, pyelonephritis, sepsis, decubitus ulcer stage III+, recurrent fever despite abx.
Cancer
Metastatic disease declining despite treatment or patient declines further disease-directed therapy. Poor performance status (ECOG 3โ4). Progressive despite โฅ 2 lines of therapy. Hypercalcemia, malignant effusions, cachexia.
CKD stage 5 (GFR < 15) and patient declines or discontinues dialysis. Creatinine clearance < 10 mL/min (CrCl < 15 for diabetics). Uremic symptoms not being treated with RRT.
Stroke / Neurologic
Coma or persistent vegetative state. Dysphagia with aspiration + declining to PEG. Progressive decline despite rehab. Recurrent aspiration pneumonia.
What Hospice Provides
Covered by Medicare Part A -no out-of-pocket cost to patient for hospice services
Includes: RN visits (typically 1โ3ร/week), aide visits, social worker, chaplain, medications related to terminal diagnosis, DME (hospital bed, Oโ, wheelchair), continuous care during crises, respite care (5 days), bereavement support for 13 months after death
Does NOT mean stopping all meds. Comfort medications continue (pain, nausea, dyspnea, anxiety). Disease-modifying meds may continue if they provide symptom benefit. Temel et al., 2010
Can be revoked at any time -patient can re-elect curative care if they change their mind
๐ On Rounds
Pimp Questions
A family asks: 'Does hospice mean you're giving up on my father?' How do you respond?
This is one of the most important conversations in medicine. The key reframe: 'Hospice isn't giving up -it's refocusing.' We're shifting from treatments that aren't working to treatments that improve quality of life. Hospice provides more care, not less: a nurse visits regularly, medications for comfort are covered, a chaplain and social worker support the family, and there's 24/7 phone access for crises.
What is the difference between hospice and palliative care?
Palliative care can be provided at any stage of serious illness, alongside curative treatment. It focuses on symptom management, goals of care, and quality of life. There is no prognosis requirement. Hospice is a specific Medicare benefit for patients with prognosis โค 6 months who elect comfort-focused care (no curative-intent treatments). Think of it this way: all hospice is palliative care, but not all palliative care is hospice.
What are the general hospice eligibility criteria beyond disease-specific ones?
General LCD (Local Coverage Determination) criteria: (1) Prognosis โค 6 months if disease runs its usual course (certified by 2 physicians), (2) Patient has elected comfort-focused care (no curative-intent treatments), (3) Functional decline: PPS (Palliative Performance Scale) โค 50% or declining, increasing dependence in ADLs, spending > 50% of day in bed
What symptoms can hospice patients still receive treatment for?
Hospice is NOT withdrawal of all treatment -it's refocusing on comfort. Hospice covers: (1) Pain: opioids, adjuvants (gabapentin, duloxetine, dexamethasone), nerve blocks, radiation for bone mets pain. (2) Dyspnea: morphine (first-line, low-dose), supplemental Oโ for comfort (not to chase SpOโ), fan directed at face, benzodiazepines if anxiety-related. (3) Nausea: ondansetron, haloperidol, metoclopramide, dexamethasone
๐ฃ Sample Presentation
One-Liner
"Mrs. Martinez is a 78-year-old with metastatic pancreatic cancer, declining PPS (30%), unable to eat or ambulate, with increasing pain and dyspnea. Oncology confirms no further disease-directed therapy. Family meeting held -patient and family electing hospice."
Key Points to Cover on Rounds
Goals of care discussion completed using REMAP framework. Patient priorities: comfort, being at home, no more ER visits. Prognosis: weeks to low months (PPS 30%, declining trajectory). Code status: DNR/DNI documented and in chart. Hospice eligibility: metastatic cancer with declining functional status despite treatment -meets LCD criteria. Hospice agency contacted -admission tomorrow. Comfort medications ordered: morphine 5 mg PO q4h PRN pain, lorazepam 0.5 mg SL q4h PRN anxiety, ondansetron 4 mg q6h PRN nausea, glycopyrrolate 0.2 mg SL q4h PRN secretions. Unnecessary meds stopped: statin, metformin, lisinopril. Hospital bed and Oโ arranged for home.
PPS trending. Declining PPS confirms trajectory. Document for recertification
Medication review
Each visit
Are comfort meds working? Side effects? Need dose adjustment? Route change needed?
Caregiver assessment
Each visit
Burnout, coping, need for respite care, bereavement risk assessment
Labs
Generally NOT indicated
Labs rarely change management in hospice. Only draw if result will change comfort plan
Recertification
90 days, 90 days, then 60-day periods
Two physicians must certify continued eligibility. Document ongoing decline
Less is more in hospice monitoring. Stop checking labs that won't change management. Focus on symptoms, comfort, and family support -not numbers.
Monitoring Parameters -Opioid Rotation
Parameter
Frequency
Target / Action
Pain scores
q4h + 1h after each PRN dose
Target โค 4/10 or functional goals (e.g., able to ambulate, sleep). Track breakthrough use -if > 3 PRN doses/day, increase scheduled dose.
Sedation (Pasero Opioid-Induced Sedation Scale)
q4h with vitals (q1โ2h first 24h post-rotation)
S = sleep, easy to arouse; 1 = awake, alert (acceptable); 2 = slightly drowsy (acceptable); 3 = frequently drowsy (hold dose, reduce); 4 = somnolent (hold, consider naloxone). Naloxone (Narcan) must be at bedside.
Respiratory rate
q4h (q1h first 24h of new opioid)
RR < 10 โ hold opioid. RR < 8 or unresponsive โ naloxone 0.04โ0.4 mg IV (titrate to respirations, not consciousness). Monitor closely ร 48โ72h after rotation.
Bowel regimen
Daily assessment (BM frequency)
Start bowel regimen with ALL opioids, PEG 3350 (MiraLAX) 17g daily + senna 8.6 mg BID. No BM ร 3 days โ add bisacodyl or methylnaltrexone (Relistor) 12 mg SC if refractory. Tolerance does NOT develop to constipation. Do not use docusate (no better than placebo, AGA-ACG 2023).
Pruritus
Each assessment
Common opioid side effect (histamine release). Rotation may resolve it. Treat with low-dose nalbuphine 2.5 mg IV or hydroxyzine 25 mg PO. Avoid diphenhydramine (additive sedation).
Nausea
Each assessment
Often resolves with rotation. Ondansetron 4 mg IV/PO q8h PRN. Haloperidol 0.5โ1 mg PO/IV for refractory opioid-induced nausea.
Functional status
Daily
Can the patient ambulate, participate in PT, perform ADLs? Pain management goal is function, not a number. Reassess total opioid requirements and consider multimodal adjuncts.
Monitor closely ร 48โ72h after any opioid rotation. Incomplete cross-tolerance means the new opioid may be unexpectedly potent. Have naloxone (Narcan) at bedside for all patients on opioid drips or after recent rotation. Adjust based on pain scores, breakthrough use, and side effect profile.
Prognostic tools: "Surprise question" -would you be surprised if this patient died in 6 months? Disease-specific criteria (see Criteria tab)
Goals of care discussion: Use REMAP framework -Reframe, Expect emotion, Map values, Align, Plan. Document in chart
Review active medications: Identify meds to continue (comfort) vs discontinue (no longer beneficial). Stop statins, metformin, vitamins, screening meds
Code status: Confirm and document DNR/DNI. Ensure POLST/MOLST form completed
Caregiver assessment: Evaluate family support, caregiver burnout risk, need for respite care
๐ Medications
Comfort Medications in Hospice
Symptom
First-Line
Dose
Notes
Pain
Morphine
5-10 mg PO q4h PRN; 2-4 mg IV/SC q2h PRN
Gold standard. Also treats dyspnea. Reduce dose in renal failure
Pain (renal failure)
Hydromorphone
0.5-1 mg PO q4h PRN
Safer than morphine in CKD/ESRD -no active metabolites
Pain (neuropathic)
Gabapentin
100-300 mg TID, titrate
Adjuvant for neuropathic pain. Also helps anxiety/insomnia
Dyspnea
Morphine
2.5-5 mg PO q4h PRN
Low-dose morphine is first-line. Fan to face also effective
Nausea
Ondansetron
4 mg PO/IV q6h PRN
First-line. Haloperidol 0.5-1 mg PO/IV q6h is excellent alternative
Secretions (death rattle)
Glycopyrrolate
0.2 mg SL/SC q4h PRN
Does not cross BBB (less delirium). Atropine 1% drops SL also works
Agitation/delirium
Haloperidol
0.5-2 mg PO/IV/SC q4-6h
First-line for terminal delirium. Add lorazepam if refractory
Anxiety
Lorazepam
0.5-1 mg PO/SL q4-6h PRN
Short-acting. Can be given sublingual if unable to swallow
Constipation
PEG 3350 + senna
Senna 2 tabs BID + MiraLAX 17g daily
Start with opioids. Methylnaltrexone SC if refractory. Docusate ineffective (AGA-ACG 2023)
Key principle: Route matters at end of life. When patients can no longer swallow, switch to SL (sublingual), SC (subcutaneous), or rectal routes. IV access is rarely needed in hospice.
โก Summary
Summary
Eligibility
Prognosis โค 6 months if disease runs its usual course. Patient elects comfort. Certified by 2 physicians. Can be revoked if patient improves.
Caregiver burnout is real. Hospice provides: respite care (5 days), bereavement counseling ร 13 months post-death, 24/7 nurse phone access.
โก Management
Hospice Management Priorities
Symptom management is the primary goal. Pain, dyspnea, nausea, agitation -treat aggressively. There is no ceiling dose for opioids in hospice if symptoms persist
Anticipatory prescribing: Write PRN orders for common end-of-life symptoms BEFORE they occur -pain, dyspnea, secretions, agitation, nausea, fever
Crisis plan: Document what to do for symptom emergencies. Continuous care (24h nursing) available for crises. Avoid unnecessary 911 calls/ER visits
Family education: Prepare family for signs of active dying -Cheyne-Stokes breathing, mottling, decreased urine output, terminal restlessness, changes in consciousness
Spiritual/psychosocial care: Chaplain, social worker, life review, legacy work. Address existential distress
๐ One Pager
Palliative Care ยท One Pager
Hospice
Prognosis โค 6 months. Comfort-focused. Active symptom management + family support. Can be revoked if patient improves. Hospice โ giving up.
Pain: morphine (first-line). Dyspnea: morphine + fan at face. Nausea: ondansetron, haloperidol. Secretions: glycopyrrolate/atropine drops. Agitation: haloperidol, lorazepam.
๐ What to Stop
Statins, metformin, vitamins, screening tests, antihypertensives (unless symptomatic). Each med removed = reduced pill burden + side effects. Focus on comfort and quality of life.
๐ Key Drugs
Morphine2-5 mg PO/SL q2-4h PRN
Lorazepam0.5-1 mg SL q4h PRN
Ondansetron4 mg q6h PRN
Glycopyrrolate0.2 mg SL q4h PRN
โ ๏ธ Pitfalls
Hospice = giving up (it's active symptom management + support)
Continuing aggressive meds that add no comfort benefit
Not offering hospice early enough (many patients referred too late)
Not supporting caregivers (burnout is real -hospice provides respite care)
Related Topics
Code Status & Advance DirectivesFamily Meeting FrameworkGoals of Care & Symptom ManagementNon-Opioid Symptom ManagementOpioid Rotation ConversionPalliative Extubation